药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Fenoldopam
Isometheptene
The risk or severity of methemoglobinemia can be increased when Phenobarbital is combined with Isometheptene.
Fenoldopam
Phenazopyridine
The risk or severity of methemoglobinemia can be increased when Phenobarbital is combined with Phenazopyridine.
Fenoldopam
Nitrous oxide
The risk or severity of methemoglobinemia can be increased when Phenobarbital is combined with Nitrous oxide.
Fenoldopam
Amyl Nitrite
The risk or severity of methemoglobinemia can be increased when Phenobarbital is combined with Amyl Nitrite.
Fenoldopam
Segesterone acetate
The metabolism of Segesterone acetate can be increased when combined with Phenobarbital.
Fenoldopam
Belantamab mafodotin
Phenobarbital may increase the excretion rate of Belantamab mafodotin which could result in a lower serum level and potentially a reduction in efficacy.
Fenoldopam
Taurocholic acid
Phenobarbital may increase the excretion rate of Taurocholic acid which could result in a lower serum level and potentially a reduction in efficacy.
Fenoldopam
Cholic Acid
Phenobarbital may increase the excretion rate of Cholic Acid which could result in a lower serum level and potentially a reduction in efficacy.
Fenoldopam
Budesonide
Phenobarbital may increase the excretion rate of Budesonide which could result in a lower serum level and potentially a reduction in efficacy.
Fenoldopam
Glycyrrhizic acid
Phenobarbital may increase the excretion rate of Glycyrrhizic acid which could result in a lower serum level and potentially a reduction in efficacy.
Fenoldopam
Pilsicainide
Phenobarbital may increase the excretion rate of Pilsicainide which could result in a lower serum level and potentially a reduction in efficacy.
Fenoldopam
Indocyanine green acid form
Phenobarbital may increase the excretion rate of Indocyanine green acid form which could result in a lower serum level and potentially a reduction in efficacy.
Fenoldopam
Prasterone sulfate
Phenobarbital may increase the excretion rate of Prasterone sulfate which could result in a lower serum level and potentially a reduction in efficacy.
Fenoldopam
Glycochenodeoxycholic Acid
Phenobarbital may increase the excretion rate of Glycochenodeoxycholic Acid which could result in a lower serum level and potentially a reduction in efficacy.
Fenoldopam
Aripiprazole lauroxil
The serum concentration of aripiprazole, an active metabolite of Phenobarbital, can be decreased when used in combination with Aripiprazole lauroxil.
Fenoldopam
Hydrocodone
The metabolism of Hydrocodone can be increased when combined with Phenobarbital.
Fenoldopam
Lofexidine
The therapeutic efficacy of Phenobarbital can be increased when used in combination with Lofexidine.
Fenoldopam
Secretin human
The therapeutic efficacy of Secretin human can be decreased when used in combination with Phenobarbital.
Fenoldopam
Deutetrabenazine
The risk or severity of sedation and somnolence can be increased when Phenobarbital is combined with Deutetrabenazine.
Fenoldopam
Tetrabenazine
The risk or severity of sedation and somnolence can be increased when Phenobarbital is combined with Tetrabenazine.